141 Notes on the Accounts for the year ended 31st March 2014 1 Segmental information continued The groups country of domicile is the UK.
Revenue from external customers is based on the customers location.
Non-current assets are based on the location of the assets and exclude financial assets, deferred tax assets and post-employment benefit net assets.
Revenue from external customers Non-current assets 2014 2013 2014 2013 restated million million million million UK 3,063.5 2,818.5 735.9 698.2 Germany 911.3 679.5 217.4 220.7 Rest of Europe 1,431.5 1,177.3 252.3 269.2 USA 2,467.3 3,096.0 355.8 369.3 Rest of North America 126.9 85.4 31.0 26.8 China including Hong Kong 1,744.0 1,527.0 72.0 63.9 Rest of Asia 941.4 846.0 107.1 121.0 Rest of World 469.3 499.1 19.2 28.3 Total 11,155.2 10,728.8 1,790.7 1,797.4 2 Revenue 2014 2013 million million Sale of goods 10,916.2 10,482.1 Rendering of services 187.6 193.2 Royalties and licence income 51.4 53.5 Total revenue 11,155.2 10,728.8 3 Major impairment and restructuring charges for year ended 31st March 2013 During the year ended 31st March 2013 the group commenced a restructuring of its global active pharmaceutical ingredient API manufacturing business.
This gave rise to a pre-tax impairment and restructuring charge of 14.2 million.
During the year ended 31st March 2013 the group liquidated an Irish subsidiary and an Australian subsidiary and so reclassified 4.6 million of cumulative exchange losses from equity to major impairment and restructuring charges.
During the year ended 31st March 2011 the group announced it was starting consultation with the Works Council about the closure of its autocatalyst facility in Brussels.
The plant ceased production in July 2011, the closure of the site then commenced and was completed during the year ended 31st March 2013.
This gave rise to a pre-tax impairment and restructuring charge of 57.0 million estimated in the year ended 31st March 2011.
1.4 million was credited to major impairment and restructuring charges in the year ended 31st March 2013.
These are excluded from underlying operating profit in the year ended 31st March 2013.
There is no impact in the consolidated income statement in the year ended 31st March 2014.
4 Amortisation of acquired intangibles The amortisation of intangible assets which arise on the acquisition of businesses, together with any subsequent impairment of these intangible assets, is shown separately on the face of the income statement.
It is excluded from underlying operating profit.
Other Information Accounts Governance Strategic Report
